Guido M. Sclabas

Learn More
Molecular Cancer has been launched for one year now. Here, we describe achievements of the past year and future goals of the journal. Editorial It is a time of change [1]. There is no doubt that the uncen-sored exchange of scientific results hastens progress and will be the gold standard for any journal [2–7]. BioMed Central, the publisher of Molecular(More)
Molecular Cancer is as a forum for cutting edge cancer-related papers. This editorial will answer frequently asked question about this open-access and on-line journal as well as its publisher BioMed Central. Editorial There is no question that immediate and unrestricted access to information stimulates scientific communication. The Freedom of Information(More)
"BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime." The data published in this article [1] and in a subsequent article in Molecular Cancer [2] were generated by myself, the corresponding author, with collaborators in Germany. The data were originally part of a manuscript on which(More)
  • 1